Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation

The cytogenetic abnormalities in non-small-cell lung cancer remain elusive due primarily to the difficulty in obtaining metaphase spreads from solid tumours. We have used the molecular cytogenetic techniques of multicolour fluorescent in situ hybridisation (M-FISH) and comparative genomic hybridisation (CGH) to analyse four primary non-small-cell lung cancer samples and two established cell lines (COR-L23 and COR-L105) in order to identify common chromosomal aberrations. CGH revealed regions on 5p, 3q, 8q, 11q, 2q, 12p and 12q to be commonly over-represented and regions on 9p, 3p, 6q, 17p, 22q, 8p, 10p, 10q and 19p to be commonly under-represented. M-FISH revealed numerous complex chromosomal rearrangements. Translocations between chromosomes 5 and 14, 5 and 11 and 1 and 6 were observed in three of the six samples, with a further 14 translocations being observed in two samples each. Loss of the Y chromosome and gains of chromosomes 20 and 5p were also frequent. Chromosomes 4, 5, 8, 11, 12 and 19 were most frequently involved in interchromosomal translocations. Further investigation of the recurrent aberrations will be necessary to identify the specific breakpoints involved and any role they may have in the aetiology, diagnosis and prognosis of non-small-cell lung cancer.

[1]  F. Mitelman ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[2]  S. Manoir,et al.  Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. , 1997, Cancer research.

[3]  J. Gusella,et al.  A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. , 2000, Cancer research.

[4]  N. Bleehen,et al.  Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). , 1985, British Journal of Cancer.

[5]  M. Tsao,et al.  Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. , 2001, Cancer genetics and cytogenetics.

[6]  B. Gunawan,et al.  Molecular cytogenetic analysis of two primary squamous cell carcinomas of the lung using multicolor fluorescence in situ hybridization , 2001, Virchows Archiv.

[7]  F. Mitelman,et al.  Recurrent chromosome aberrations in cancer. , 2000, Mutation research.

[8]  A Kuzucu,et al.  Cytogenetic findings in thirty lung carcinoma patients. , 1998, Cancer genetics and cytogenetics.

[9]  M. Lind,et al.  Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization , 2002, International journal of cancer.

[10]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[11]  S. Knuutila,et al.  A broad amplification pattern at 3q in squamous cell lung cancer--a fluorescence in situ hybridization study. , 2000, Cancer genetics and cytogenetics.

[12]  M. Augustus,et al.  Cytogenetics of non-small cell lung cancer: simple technique for obtaining high quality chromosomes by fine needle aspirate cultures. , 1996, Cancer genetics and cytogenetics.

[13]  P. Drew,et al.  Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. , 2002, International journal of oncology.

[14]  S. Ell,et al.  Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. , 1999, Archives of otolaryngology--head & neck surgery.

[15]  S. Knuutila,et al.  DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma , 1998, Genes, chromosomes & cancer.

[16]  R. Eils,et al.  Analysis of Chromosomal Alterations in Non-Small Cell Lung Cancer by Multiplex-FISH, Comparative Genomic Hybridization, and Multicolor Bar Coding , 2000, Laboratory Investigation.

[17]  S. Petersen,et al.  Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. , 1997, Cancer research.

[18]  M. Fukuoka,et al.  Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4). , 1991, Chest.

[19]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[20]  R. Kobayashi,et al.  pl9 skp1 and p45 skp2 are essential elements of the cyclin A-CDK2 S phase kinase , 1995, Cell.

[21]  S. Petersen,et al.  Chromosomal alterations in the clonal evolution to the metastatic stage ofquamous cell carcinomas of the lung , 1999, British Journal of Cancer.

[22]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[23]  S. Petersen,et al.  Chromosomal imbalances of primary and metastatic lung adenocarcinomas , 2002, The Journal of pathology.

[24]  J. Siegfried,et al.  Cytogenetic analysis of 63 non‐small cell lung carcinomas: Recurrent chromosome alterations amid frequent and widespread genomic upheaval , 1994, Genes, chromosomes & cancer.

[25]  D. Ward,et al.  Karyotyping human chromosomes by combinatorial multi-fluor FISH , 1996, Nature Genetics.

[26]  Y. Nakamura,et al.  Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.